RT @CVIR_Journal: #tb to 2019 ↩️ Segment 2/3 Hypertrophy is Greater When Right Portal Vein #Embolisation is Extended to Segment 4 in Patien…
#tb to 2019 ↩️ Segment 2/3 Hypertrophy is Greater When Right Portal Vein #Embolisation is Extended to Segment 4 in Patients with Colorectal #Liver Metastases: A Retrospective Cohort Study https://t.co/0BQynehoQf #OpenAccess https://t.co/CxOYQiaT2o
RT @CVIR_Journal: Back to 2019 ⬅️ Segment 2/3 Hypertrophy is Greater When Right Portal Vein #Embolisation is Extended to Segment 4 in Patie…
Back to 2019 ⬅️ Segment 2/3 Hypertrophy is Greater When Right Portal Vein #Embolisation is Extended to Segment 4 in Patients with Colorectal #Liver Metastases: A Retrospective Cohort Study https://t.co/0BQyneyZHN @doctorhammond #OpenAccess https://t.co/X
RPVE + 4 results in greater DH of segments 2/3 than RPVE in people with CLRM! https://t.co/ykcX9dYZff #IRad #colorectalcancer @doctorhammond @LeedsHospitals @LeedsMedHealth #FOAMed https://t.co/p1Jx7yV5md
RT @dcmadoff: Thanks @doctorhammond for sharing! We have been advocating this approach since our @JVIRmedia paper in 2005!!! Great to see y…
RT @dcmadoff: Thanks @doctorhammond for sharing! We have been advocating this approach since our @JVIRmedia paper in 2005!!! Great to see y…
RT @dcmadoff: Thanks @doctorhammond for sharing! We have been advocating this approach since our @JVIRmedia paper in 2005!!! Great to see y…
RT @dcmadoff: Thanks @doctorhammond for sharing! We have been advocating this approach since our @JVIRmedia paper in 2005!!! Great to see y…
Thanks @doctorhammond for sharing! We have been advocating this approach since our @JVIRmedia paper in 2005!!! Great to see your group's research corroborates our findings! #irad @SIRspecialists @SIRRFS @SIR_ECS @SIO_Central @cirsesociety @BSIR_News @DDInt